Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms.

Science (New York, N.Y.) | Feb 3, 1995

http://www.ncbi.nlm.nih.gov/pubmed/7839144

Mammalian mitogen-activated protein (MAP) kinases include extracellular signal-regulated protein kinase (ERK), c-Jun amino-terminal kinase (JNK), and p38 subgroups. These MAP kinase isoforms are activated by dual phosphorylation on threonine and tyrosine. Two human MAP kinase kinases (MKK3 and MKK4) were cloned that phosphorylate and activate p38 MAP kinase. These MKK isoforms did not activate the ERK subgroup of MAP kinases, but MKK4 did activate JNK. These data demonstrate that the activators of p38 (MKK3 and MKK4), JNK (MKK4), and ERK (MEK1 and MEK2) define independent MAP kinase signal transduction pathways.

Pubmed ID: 7839144 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Base Sequence | Calcium-Calmodulin-Dependent Protein Kinases | Cell Line | Cloning, Molecular | Enzyme Activation | Humans | JNK Mitogen-Activated Protein Kinases | MAP Kinase Kinase 3 | MAP Kinase Kinase 4 | Mitogen-Activated Protein Kinase 1 | Mitogen-Activated Protein Kinase Kinases | Mitogen-Activated Protein Kinases | Molecular Sequence Data | Phosphorylation | Protein-Serine-Threonine Kinases | Protein-Tyrosine Kinases | Signal Transduction | Substrate Specificity | Transfection | p38 Mitogen-Activated Protein Kinases

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, Id: AI15136
  • Agency: NCI NIH HHS, Id: CA58396
  • Agency: NIGMS NIH HHS, Id: GM37696

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.